Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.04%
#2 Audiera Audiera +19.18%
#3 Geodnet Geodnet +10.71%
#4 Ocean Protocol Ocean Protocol +8.89%
#5 The Bitcoin Bull The Bitcoin Bull +6.72%
#6 Rollbit Coin Rollbit Coin +6.51%
#7 Quack AI Quack AI +5.98%
#8 Tutorial Tutorial +5.97%
#9 Cysic Cysic +5.70%
#10 LAB LAB +5.44%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
Hisse Senetlerindeki Sıralama #32327
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
Hisse Fiyatı
$0.88
Son senkronizasyon: 2026-08-17
Piyasa Değeri
$10.41M
Değişim (1 gün)
-7.26%
Değişim (1 yıl)
-50.56%
Ülke
SG
Ticaret CytoMed Therapeutics Limited (GDTC)

Kategori

Healthcare
CytoMed Therapeutics Limited (GDTC) için P/S oranı
2026 itibarıyla P/S oranı TTM: 0
CytoMed Therapeutics Limited şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 0'dir. 2026 yılının sonunda şirketin P/S oranı 0 idi.
CytoMed Therapeutics Limited için P/S oranı geçmişi 2026 - 2026 arası
Her yılın sonunda P/S oranı
Yıl P/S Oranı Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için P/S oranı
Şirket P/S Oranı P/S Oranı Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE